N-(Pyridin-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

2,000.00

CAS No. 1383385-64-5
Application Acalabrutinib
Synonyms 4-(2-Pyridylcarbamoyl)phenylboronic Acid Pinacol Ester, N-(pyridin-2-yl)-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
Status Kilo Lab Scale

Description

N-(Pyridin-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide (CAS 1383385-64-5)

CAS 1383385-64-5 refers to N-(Pyridin-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, an important pharmaceutical intermediate widely used in advanced chemical synthesis and API development. Punagri is a trusted supplier and manufacturer of CAS 1383385-64-5 in India, delivering high-quality material for pharmaceutical and research applications.

This compound is widely recognized as an important Acalabrutinib intermediate and supports multi-step pharmaceutical manufacturing processes. Moreover, Punagri follows controlled manufacturing practices and strict quality standards to maintain consistent product quality. Therefore, customers rely on us for dependable supply and reliable performance.

CAS 1383385-64-5 plays a significant role in pharmaceutical intermediate manufacturing, specialty chemical production, and research-based synthesis applications.


Synonyms

  • 4-(2-Pyridylcarbamoyl)phenylboronic Acid Pinacol Ester
  • N-(pyridin-2-yl)-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

Key Features

• High purity CAS 1383385-64-5 suitable for pharmaceutical synthesis
• Consistent product quality through controlled manufacturing processes
• Moreover, reliable performance for industrial and research applications
• Suitable for pharmaceutical and specialty chemical industries
• Secure packaging for safe storage and export
• Trusted supplier of CAS 1383385-64-5 in India


Applications

Acalabrutinib Intermediate

CAS 1383385-64-5 is widely used in the synthesis of Acalabrutinib, an important pharmaceutical compound used in targeted therapy development.

Pharmaceutical Manufacturing

In addition, this compound supports API development and advanced pharmaceutical intermediate synthesis.

Research & Development

Furthermore, CAS 1383385-64-5 contributes to laboratory research, process optimization, and specialty chemical development.


Why Choose Punagri?

Punagri supplies high-quality pharmaceutical intermediates with dependable service and consistent standards.

Reasons to choose Punagri:

• Trusted manufacturer and supplier of CAS 1383385-64-5
• Reliable manufacturing with strict quality monitoring
• Moreover, efficient logistics ensure timely delivery
• Competitive pricing for bulk requirements
• Secure export-ready packaging
• Long-term supply support for pharmaceutical industries

As a result, customers benefit from reliable quality and professional support.


Global Supply

Punagri supplies CAS 1383385-64-5 to pharmaceutical and chemical industries across international markets.

We serve customers in Asia, Europe, and other global regions. Furthermore, our structured supply chain ensures timely delivery and consistent product quality for every batch.

We supply CAS 1383385-64-5 to global markets with reliable logistics and consistent product performance.


Frequently Asked Questions (FAQs)

What is CAS 1383385-64-5?

CAS 1383385-64-5 refers to N-(Pyridin-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, a pharmaceutical intermediate used in chemical synthesis.

What are the applications of CAS 1383385-64-5?

CAS 1383385-64-5 is mainly used as an Acalabrutinib intermediate in pharmaceutical synthesis and specialty chemical applications.

Who supplies CAS 1383385-64-5 in India?

Punagri is a trusted supplier and manufacturer of CAS 1383385-64-5 in India.

Do you supply CAS 1383385-64-5 in bulk quantities?

Yes, we supply CAS 1383385-64-5 in bulk quantities with secure packaging and reliable delivery.

What are the synonyms of CAS 1383385-64-5?

It is also known as 4-(2-Pyridylcarbamoyl)phenylboronic Acid Pinacol Ester and N-(pyridin-2-yl)-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide.

Additional information

Application Area

Acalabrutinib